vimarsana.com

Page 345 - Weizmann Institute Of Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lysogene Enters into an Exclusive Worldwide License Agreement with Yeda, the Commercial Arm of the Weizmann Institute of Science, for a Novel Gene Therapy Candidate for Neuronopathic Gaucher Disease and Parkinson Disease with GBA1 Mutations

Lysogene exercises its option after a conclusive research collaboration period Regulatory News: Lysogene (FR0013233475 LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central

France generalAnthony futermanPralph lauferYeda researchDevelopment co ltdWeizmann institute of scienceDevelopment company ltdWeizmann instituteBusiness development at yedaElik chapnikBusiness developmentDevelopment companyLooking statementFrench autoritDes marchFrench markets authorities

Fourth Dose of BNT162b2 Offers Protection Against Severe COVID-19

The rates of confirmed SARS-CoV-2 infection and severe COVID-19 were lower after receipt of a fourth dose of the Pfizer-BioNTech vaccine.

Weizmann institute of scienceHealthday newsNew england journalWeizmann institute

Smell test almost as effective as rapid antigens at detecting COVID-19: study

An online tool which guides people how to detect COVID-19 via a simple smell test was 79 per cent effective.

Weizmann institute of scienceWeizmann instituteFederal election

Professor Goldreich Receives Israel Prize, Ending Year-long Battle

Goldreich is a computer scientist at the Weizmann Institute of Science in Rehovot - Click the link for more details.

West bankYifat shasha bitonOded goldreichYoav galantIsrael high courtWeizmann institute of scienceIsrael prizeProfessor oded goldreichWeizmann instituteEducation minister yoav galantEducation minister yifat shasha bitonHigh courtIndependence day

Fourth Dose of BNT162b2 Offers Protection Against Severe COVID-19

Protection against COVID-19 did not wane in six weeks after receipt of fourth dose; protection against infection waned.

Weizmann institute of scienceHealthday newsNew england journalWeizmann institute

vimarsana © 2020. All Rights Reserved.